X

Health Care

Earnings preview: What to look for when Gilead reports Q2 results

Gilead Sciences Inc. (NYSE: GILD) is scheduled to report second quarter 2019 earnings results on Tuesday, July 30, after market…

Sanofi slips to a loss in Q2 on Eloctate impairment charge

Sanofi (NASDAQ: SNY) slipped to a loss in the second quarter of 2019 from a profit last year, due to…

Earnings preview: A look at key factors affecting Pfizer’s Q2 results

Pfizer Inc. (NYSE: PFE) is scheduled to report second quarter 2019 earnings results on Tuesday, July 30, before market open.…

AbbVie tops Q2 views; lifts FY19 earnings outlook

AbbVie's (NYSE: ABBV) earnings and revenue for the second quarter of 2019 surpassed Wall Street's estimates. AbbVie reported adjusted EPS…

Bristol-Myers Q2 earnings, revenue top Street; stock dips on weak guidance

Biopharma company Bristol-Myers Squibb (NYSE: BMY) on Thursday reported higher earnings and revenues for the second quarter, The results also…

AstraZeneca’s Q2 results beat market expectations

AstraZeneca Plc (NYSE: AZN) topped market estimates for revenue and earnings in the second quarter of 2019, giving shares a…

What to expect from AbbVie Q2 earnings

AbbVie (NYSE: ABBV) is scheduled to report its earnings results for the second quarter of 2019 on Friday before the…

Earnings preview: Celgene deal in focus as Bristol-Myers prepares for Q2 results

Bristol-Myers Squibb (NYSE: BMY) will be releasing its quarterly results amid growing skepticism over the planned acquisition of rival drugmaker…

Boston Scientific Q2 profit dips 72% but beats estimates

Boston Scientific Corporation (NYSE: BSX) reported a 72% dip in earnings for the second quarter due to higher costs and expenses…

Earnings: Alexion Pharma Q2 results top expectations; raises FY19 guidance

Alexion Pharmaceuticals (Nasdaq: ALXN) reported a 28% growth for its second-quarter earnings, helped by an increase in revenues. The results…